253 related articles for article (PubMed ID: 19892741)
1. Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment.
Weiss JM; Back TC; Scarzello AJ; Subleski JJ; Hall VL; Stauffer JK; Chen X; Micic D; Alderson K; Murphy WJ; Wiltrout RH
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19455-60. PubMed ID: 19892741
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ -independent resolution of treated-tumors and CD4+ -dependent systemic and memory responses.
Jackaman C; Nelson DJ
Cancer Immunol Immunother; 2012 Apr; 61(4):549-60. PubMed ID: 22002241
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy.
Weiss JM; Ridnour LA; Back T; Hussain SP; He P; Maciag AE; Keefer LK; Murphy WJ; Harris CC; Wink DA; Wiltrout RH
J Exp Med; 2010 Oct; 207(11):2455-67. PubMed ID: 20921282
[TBL] [Abstract][Full Text] [Related]
4. CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity.
Huffman AP; Lin JH; Kim SI; Byrne KT; Vonderheide RH
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324594
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
[TBL] [Abstract][Full Text] [Related]
6. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
Sun Y; Peng D; Lecanda J; Schmitz V; Barajas M; Qian C; Prieto J
Gene Ther; 2000 Sep; 7(17):1467-76. PubMed ID: 11001366
[TBL] [Abstract][Full Text] [Related]
7. mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment.
Jiang Q; Weiss JM; Back T; Chan T; Ortaldo JR; Guichard S; Wiltrout RH
Cancer Res; 2011 Jun; 71(12):4074-84. PubMed ID: 21540234
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses.
Murphy WJ; Welniak L; Back T; Hixon J; Subleski J; Seki N; Wigginton JM; Wilson SE; Blazar BR; Malyguine AM; Sayers TJ; Wiltrout RH
J Immunol; 2003 Mar; 170(5):2727-33. PubMed ID: 12594303
[TBL] [Abstract][Full Text] [Related]
9. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
[TBL] [Abstract][Full Text] [Related]
10. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC.
Kuroda E; Sugiura T; Okada K; Zeki K; Yamashita U
J Immunol; 2001 Feb; 166(3):1650-8. PubMed ID: 11160207
[TBL] [Abstract][Full Text] [Related]
12. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine.
Andres PG; Beck PL; Mizoguchi E; Mizoguchi A; Bhan AK; Dawson T; Kuziel WA; Maeda N; MacDermott RP; Podolsky DK; Reinecker HC
J Immunol; 2000 Jun; 164(12):6303-12. PubMed ID: 10843684
[TBL] [Abstract][Full Text] [Related]
13. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells.
Schaniel C; Pardali E; Sallusto F; Speletas M; Ruedl C; Shimizu T; Seidl T; Andersson J; Melchers F; Rolink AG; Sideras P
J Exp Med; 1998 Aug; 188(3):451-63. PubMed ID: 9687523
[TBL] [Abstract][Full Text] [Related]
14. CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma.
Diggs LP; Ruf B; Ma C; Heinrich B; Cui L; Zhang Q; McVey JC; Wabitsch S; Heinrich S; Rosato U; Lai W; Subramanyam V; Longerich T; Loosen SH; Luedde T; Neumann UP; Desar S; Kleiner D; Gores G; Wang XW; Greten TF
J Hepatol; 2021 May; 74(5):1145-1154. PubMed ID: 33276030
[TBL] [Abstract][Full Text] [Related]
15. The role of chemokines and their receptors in the rejection of pig islet tissue xenografts.
Solomon MF; Kuziel WA; Mann DA; Simeonovic CJ
Xenotransplantation; 2003 Mar; 10(2):164-77. PubMed ID: 12588649
[TBL] [Abstract][Full Text] [Related]
16. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
17. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
[TBL] [Abstract][Full Text] [Related]
18. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines.
Kim JJ; Nottingham LK; Sin JI; Tsai A; Morrison L; Oh J; Dang K; Hu Y; Kazahaya K; Bennett M; Dentchev T; Wilson DM; Chalian AA; Boyer JD; Agadjanyan MG; Weiner DB
J Clin Invest; 1998 Sep; 102(6):1112-24. PubMed ID: 9739045
[TBL] [Abstract][Full Text] [Related]
19. The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation.
Jones HP; Hodge LM; Fujihashi K; Kiyono H; McGhee JR; Simecka JW
J Immunol; 2001 Oct; 167(8):4518-26. PubMed ID: 11591779
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis.
Zhou Q; Gault RA; Kozel TR; Murphy WJ
Infect Immun; 2006 Apr; 74(4):2161-8. PubMed ID: 16552046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
